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Abstract
Background
The importance of providing effective analgesia during sedation for complex endoscopic
procedures has been widely recognized. However, repeated administration of opioids in
order to achieve sufficient analgesia may carry the risk of delayed recovery after propofol
based sedation. This study was done to compare recovery profiles and the satisfaction of
the endoscopists and patients between conventional balanced propofol sedation and anal-
gesia-oriented combination sedation for patients undergoing endoscopic retrograde cholan-
giopancreatography (ERCP).
Methods
Two hundred and two adult patients scheduled for ERCPwere sedated by either the Conven-
tional (initial bolus of meperidine with propofol infusion) or Combination (repeated bolus doses
of fentanyl with propofol infusion) method. Recovery profiles, satisfaction levels of the endos-
copists and patients, drug requirements and complications were compared between groups.
Results
Patients of the Combination Group required significantly less propofol compared to the Con-
ventional Group (135.0 ± 68.8 mg vs. 165.3 ± 81.7 mg, P = 0.005). Modified Aldrete scores
were not different between groups throughout the recovery period, and recovery times were
also comparable between groups. Satisfaction scores were not different between the two
groups in both the endoscopists and patients (P = 0.868 and 0.890, respectively).
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Conclusions
Considering the significant reduction in propofol dose, the non-inferiority of recovery profiles
and satisfaction scores of the endoscopists and patients, analgesia oriented combination
sedation may be a more safe yet effective sedative method compared to conventional bal-
anced propofol sedation during ERCP.
Introduction
Sedation for gastrointestinal endoscopic procedures has become commonplace during the past
decade, and many attempts have been made to find a safe and yet effective combination of sed-
atives and analgesics. Despite considerable dispute, propofol has gained overall popularity as
the sedative of choice by many endoscopists and anaesthesiologists, and has largely replaced
the traditional use of benzodiazepines.[1–3] However, its lack of analgesic property, narrow
therapeutic window and absence of a reversal agent have been recognized as the cause of
adverse events related to oversedation.[4]
In an attempt to reduce these complications, balanced propofol sedation (BPS) was pro-
posed as a method that would provide safe and effective sedation by combining a low-dose of
propofol with an opioid analgesic and/or benzodiazepine.[5] While the concept of BPS has
been generally well received by the medical society, the issue of which and how much opioid
analgesic should be combined with propofol is still under debate.[6,7] The conventionally used
opioid was meperidine, and many clinicians administered this agent routinely for pain control
during endoscopic procedures. However, meperidine is quickly losing its place as an analgesic
for interventional procedures due to its many side effects and low efficacy.[8,9] The toxic
potential of meperidine renders it inappropriate for use during endoscopic retrograde cholan-
giopancreatography (ERCP), as such procedures are usually accompanied by severe pain and
discomfort which may require repeated analgesics administration.[10] On the other hand, we
found in a recent retrospective study that respiratory events were significantly reduced when
effective analgesia was provided during ERCP by giving bolus doses of fentanyl as needed.[11]
However, repeated doses of fentanyl may carry the risk of prolonged recovery time, which
could be a problem in terms of patient safety and efficiency.
This randomized, controlled trial was conducted to compare recovery profiles between con-
ventional BPS using a single dose of meperidine and a combination method using repeated
doses of fentanyl during propofol-based sedation for ERCP. We hypothesized that a combina-
tion method would be able to offer satisfactory sedation without prolonging recovery times
compared to conventional BPS. Satisfaction levels of the endoscopists and patients as well as
drug requirements, cardiovascular and respiratory events were also assessed and compared
between the two groups.
Methods
Ethics statement
The study protocol was approved by the Institutional Review Board and Hospital Research
Ethics Committee of Severance Hospital, and registered at http://clinicaltrials.gov (registration
number NCT01840371).
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Study population
Adult patients of American Society of Anesthesiologists (ASA) physical status I ~ IV that were
scheduled for elective ERCP between April 2013 and October 2013 were recruited for this
study. All patients provided written informed consent. Pregnant or breastfeeding patients and
those with known allergies to eggs, soy beans or sulfites were excluded from this study. Patients
that had received sedation for another procedure within 24 hours prior to ERCP, were unable
to provide informed consent or were under the age of 20 years were also excluded.
Study design and sedation protocols
The targeted level of sedation was MOAA/S (Modified Observer’s Assessment of Alertness/
Sedation Scale) score 3 to 4 in all patients. Sedation in the Conventional Group was done by
administrating 25 mg of IV meperidine (Pethidine, Jeil Pharmaceutical Co. Lt., Daegu, Korea)
and 1 mg kg-1 of propofol (Pofol, Dong Kook Pharmaceutical Co. Ltd., Seoul, Korea) initially,
followed by propofol infusion at a maintenance rate of 60 μg min-1kg-1 using an automated
pump (Terufusion1 Syringe Pump TE-331, Terumo Corporation, Tokyo, Japan). Additional
doses of 10 mg of propofol were given when patients complained of discomfort/pain, or when
the endoscopist demanded deeper sedation. Patients of the Combination Group were given
1 μg kg-1 of IV fentanyl (Hana pharmaceutical, Korea) and 0.4 mg kg-1 of propofol initially, fol-
lowed by propofol infusion at a maintenance rate of 30 μg min-1 kg-1. Additional doses of 10
mg of propofol were given during insufficient sedation, while bolus doses of 0.5 μg kg-1 of fen-
tanyl were given when additional analgesia was needed. The need for additional sedation and
analgesia was judged by the attending anesthesiologist based on the visual observation of
patient irritability or excessive movement. Benzodiazepines were not used in our study.
Enrolled patients were randomly assigned to either the Conventional Group (n = 100) or
the Combination Group (n = 102) by means of a table of random numbers generated by 4
block design with the SAS program (SAS institute Inc., Cary, NC, USA). The allocation
sequence was assigned to each patient in sealed envelopes with equal randomization (1:1 for
the two groups) at the point of sedation induction. The patients, all study investigators and
medical personnel except the attending anesthetist providing sedation were blinded to group
assignment. All ERCP procedures were performed by 5 endoscopists of similar experience
(who performed more than 300 ERCPs annually for more than 3 years) and sedation was done
by a qualified anesthesiology staff member trained for procedural sedation outside the operat-
ing theater that was not involved in the study.
Patient monitoring
All endoscopic procedures were performed in a room dedicated to ERCP, fully equipped for
advanced cardiac life support. Patients arrived at the endoscopy room with secure IV access,
and nasal oxygen was supplied at 3 L min-1. Patient monitoring included non-invasive blood
pressure measurement every 5 minutes, pulse oximetry (SpO2) and electrocardiography.
Recovery score assessment using the modified Aldrete score[12] was initiated immediately
after the procedure ended (0 minutes), and was followed at 5, 15 and 25 minutes post-proce-
dure by a nurse that was blinded to the sedation regimen at the endoscopy recovery unit.
Outcome measurements and definitions
The primary outcome of this study was to compare recovery profiles between the two groups.
In addition to assessing recovery based on the modified Aldrete score at the aforementioned
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time points, time required for full recovery was noted. Recovery time was defined as the time
interval between scope withdrawal and the modified Aldrete score reaching 10 points.
The endoscopists gave a satisfaction score at the end of the procedure, and patients were
asked by a nurse that was blinded to the sedation regimen to give a score upon full recovery at
the endoscopy recovery unit. Satisfaction scores were initially given on a verbally administered
numerical rating scale of 0 to 100.
Procedure duration was defined as the time between scope insertion and scope withdrawal.
Adverse respiratory events such as desaturation and apnea were also recorded by the attending
anesthetist and compared between the two groups. Desaturation was defined as SpO2 lower
than 90% for more than 10 seconds that required either an increase in O2 supply, chin lift, jaw
thrust maneuver or assisted mask ventilation at the discretion of the attending anesthetist.
Apnea was defined as the cessation of voluntary respiration for more than 30 seconds under
visual observation. Hypertension due to severe pain or undersedation was defined as more
than a 20% increase of mean blood pressure (MBP) from baseline, and hypotension was
defined as systolic blood pressure (SBP)< 90 mmHg or MBP< 60 mmHg. Bradycardia and
tachycardia were each defined as heart rate (HR)< 60 bpm and> 100 bpm, respectively.
Post-procedure pain scores were recorded on a visual analogue scale (VAS) of 0–10 at 6, 12,
18 and 24 hours. The number of times rescue analgesics or antiemetics were administrated
were recorded during intervals of 0–12 hours and 12–24 hours after the procedure.
Statistical analysis
A Sample size was calculated based on the recovery times after propofol monosedation
reported in a previous study.[7] To detect a 20% difference in recovery time with a non-inferi-
ority design between groups, 100 patients per group would be required to obtain a power of
85%, assuming a type I error of 0.05. Continuous variables with normal distribution were ana-
lyzed with the independent two sample t-test. Continuous variables that were not normally dis-
tributed were analyzed with the Mann-Whitney U Test and expressed as median and
interquartile range (IQR). Categorical variables were analyzed by the Chi-square or Fisher’s
exact test. All statistical analyses were performed with IBM SPSS Statistics 20.0 (IBM Corp.,
Armonk, NY, USA). A P value of< 0.05 was considered statistically significant. Data are
described as mean ± SD or number of subjects.
Results
The CONSORT flow diagram of this study is shown in Fig 1. Of the 232 patients that were
assessed for eligibility, 12 patients that received propofol sedation for endoscopic ultrasound
just before ERCP and another 5 patients in whom ERCP was cancelled were excluded from this
study. The remaining 215 patients were randomly assigned to either the Conventional Group
(n = 107) or the Combination Group (n = 108). After randomization, 7 patients in the Conven-
tional Group and 6 patients in the Combination Group were dropped from analysis due to
incomplete medical records or missing data at the time of analysis. The remaining 202 patients
(100 and 102 patients of the Conventional Group and Combination Group, respectively) suc-
cessfully completed the study and were included for analysis.
Patient characteristics
Patient characteristics and procedure-related data are listed in Table 1. While there were no
difference in patient characteristics with regard to gender, body mass index, history of smok-
ing, alcohol intake or snoring and ASA classification, the patients in the Combination Group
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were significantly older than those of the Conventional Group (P = 0.025). Reason for ERCP
and type of performed ERCP were not significantly different between the two groups.
Drug requirements and procedure duration
Patients in the Combination Group required significantly less propofol compared to the Con-
ventional Group (135.0 ± 68.8 mg vs. 165.3 ± 81.7 mg, P = 0.005). Procedure duration of the
Conventional Group and the Combination Group were not significantly different (19.9 ± 13.4
and 21.4 ± 13.6 minutes, respectively, P = 0.445) (Table 2).
Cardiovascular and respiratory parameters
Cardiovascular and respiratory data were shown in Table 3. Baseline vital signs including mean
blood pressure, heart rate and SpO2 were not different between the two groups. The number of
patients that presented with significant hypertension or hypotension was not different between
the two groups. Similarly, there was no difference in the incidence of tachycardia or bradycar-
dia between groups. Two patients (2.0%) in the Conventional Group and 3 patients (2.9%) in
the Combination Group experienced desaturation (P = 0.287), and all events were resolved
with a temporary increase in oxygen flow without the need of scope removal. None of the
patients required vasopressors, endotracheal intubation or premature termination of ERCP
due to sedation-related complications.
Recovery profiles and satisfaction scores
Modified Aldrete scores at 0, 5, 15 and 25 minutes after the procedure were not different
between the two groups at any of the time points. Recovery times of the Conventional Group
and the Combination Group were also comparable between groups [13 (5, 20) and 12 (5, 19)
minutes, respectively, P = 0.662] (Table 4). Satisfaction scores of the endoscopists and patients
were also not different between the two groups (P = 0.868 and 0.890, respectively) (Table 5).
Fig 1. CONSORT flowchart.
doi:10.1371/journal.pone.0138422.g001
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Pain scores and rescue drug administration
Pain scores were significantly lower in the Combination Group compared to the Conventional
Group at post-procedure 6 hours (2.5 ± 2.5 vs. 3.2 ± 2.4, P = 0.045) but not at 12, 18 or 24
Table 1. Patient characteristics. Values are mean ± SD or number (%) of patients. ERCP, endoscopic retrograde cholangiopancreatography. ASA, Ameri-
can Society of Anesthesiologists
Variables Conventional Group (n = 100) Combination Group (n = 102) P-value
Age (years) 60.9 ± 14.6 65.3 ± 13.8 0.025•
Gender (male/female) 52 / 48 60 / 42 0.329••
Body mass index (kg/m2) 22.8 ± 3.0 23.1 ± 3.2 0.454•
Smoking History 0.387••
Yes 15 (15.0) 20 (19.6)
No 85 (85.0) 82 (80.4)
Alcoholic History 0.238••
Yes 16 (16.0) 23 (22.5)
No 84 (84.0) 79 (77.5)
Snoring History 0.259••
Yes 12 (12.0) 18 (17.6)
No 88 (88.0) 84 (82.4)
ASA class 0.427••
1 11 (11.0) 13 (12.7)
2 45 (45.0) 35 (34.3)
3 40 (40.0) 47 (46.1)
4 4 (4.0) 7 (6.9)
Reason for ERCP 0.840••
Bile duct cancer 21 (21.0) 25 (24.5)
Pancreatic cancer 15 (15.5) 12 (11.8)
Other malignancy 8 (8.0) 7 (6.9)
Choledocholithiasis 44 (44.0) 49 (48.0)
Miscellaneous 12 (12.0) 9 (8.8)
Type of ERCP 0.63••
Diagnostic 13 (13.0) 9 (8.8)
Diagnostic and therapeutic 81 (81.0) 87 (85.3)
Failed cannulation 6 (6.0) 6 (5.9)
•Analyzed with the independent two sample t-test,
••Analyzed with the Chi-square or Fisher’s exact test
doi:10.1371/journal.pone.0138422.t001
Table 2. Drug requirements and procedure duration. Values are mean ± SD (range).
Conventional Group (n = 100) Combination Group (n = 102) P-value•
Drug requirements
Propofol (mg) 165.3 ± 81.7 (40 to 390) 135.0 ± 68.8 (30 to 360) 0.005
Fentanyl (μg) - 107.2 ± 46.8 (40 to 300) -
Propofol (μg/kg/min) 185.5 ± 134.5 129.6 ± 77.5 < 0.001
Procedure duration (min) 19.9 ± 13.4 21.4 ± 13.6 0.445
•Analyzed with the independent two sample t-test
doi:10.1371/journal.pone.0138422.t002
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hours. The frequency of rescue analgesics administration was also significantly lower in the
Combination group during the first 12 hours after the procedure (0.08 ± 0.9 vs. 0.5 ± 0.8,
P = 0.023) but not between 12 and 24 hours. There was no difference between the two groups
in the number of times rescue anti-emetics were given during 24 hours after the procedure
(Table 6).
Discussion
Since BPS was first described by Cohen et al.,[13] propofol-based sedation methods for endo-
scopic procedures have gained much popularity. However, the debate on which regimen
should be used is yet to be resolved. Sedation regimens cannot be standardized, but should be
tailored according to the characteristics of the procedure such as the target site, duration, the
general condition of the patient and nature of the intended procedure. Therefore, the relatively
complex nature of ERCP procedures render it even more difficult to choose a safe and effective
sedation regimen compared to simpler endoscopic procedures such as colonoscopy or esopha-
gogastroduodenoscopy. We found in the present study that combining repeated doses of fenta-
nyl for adequate pain control with continuous propofol infusion does not seem to prolong
recovery times compared to a single dose of meperidine followed by continuous propofol infu-
sion. Moreover, the proportion of endocopists and patients that felt ‘very unsatisfied’ with the
overall sedation method were clearly smaller in the Combination Group.
Appropriate analgesia has emerged as an important aspect to consider when deciding on a
sedation regime. Jeurnink et al.[10] reported that more discomfort was experienced during and
immediately after the procedure in patients that underwent therapeutic ERCP compared to
diagnostic ERCP. They also concluded that one-third to one-half of patients undergoing ERCP
Table 3. Cardiovascular and respiratory parameters. Values are mean ± SD or n (%) of patients. MBP, mean blood pressure. HR, heart rate
Conventional Group (n = 100) Combination Group (n = 102) P-value
Baseline MBP (mmHg) 87 ± 15 90 ± 16 0.160•
Hypertension 22 (22.0) 21 (20.6) 0.806••
Hypotension 9 (9.0) 11 (10.8) 0.671••
Baseline HR (beats per minute) 89 ± 13 91 ± 19 0.283•
Tachycardia 34 (34.0) 39 (38.2) 0.531••
Bradycardia 4 (4.0) 3 (2.9) 0.681••
Baseline SpO2 (%) 99.4 ± 1.6 99.6 ± 0.9 0.237
•
SpO2 < 90% 2 (2.0) 3 (2.9) 0.287
••
•Analyzed with the independent two sample t-test,
••Analyzed with the Chi-square or Fisher’s exact test
doi:10.1371/journal.pone.0138422.t003
Table 4. Recovery profiles. Values are median (IQR)
Conventional Group (n = 100) Combination Group (n = 102) P-value•
Aldrete score at 0 min 8 (7, 9) 8 (7, 9) 0.217
Aldrete score at 5 min 9 (8, 10) 9 (8, 10) 0.379
Aldrete score at 15 min 10 (9, 10) 10 (9, 10) 0.159
Aldrete score at 25 min 10 (10, 10) 10 (10, 10) -
Recovery time (minutes) 13 (5, 20) 12 (5, 19) 0.662
• Analyzed with the Mann-Whitney U Test
doi:10.1371/journal.pone.0138422.t004
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under conscious sedation experience discomfort and pain, implying that pain was often under-
treated during and after these procedures. In the same vein, we found in a recent retrospective
study that more opioids were administered during therapeutic ERCP compared to diagnostic
procedures when performed under conscious sedation with propofol infusion.[11] The results
of these studies point in the same direction—a need for more attention towards analgesia dur-
ing ERCP, and especially during therapeutic procedures.
The concept of BPS basically involves a single induction dose of opioid and/or benzodiaze-
pine, followed by incremental doses of propofol in order to achieve a targeted level of moderate
sedation.[14] However, it is important to recognize that propofol does not have any inherent
analgesic properties and therefore requires an adjuvant drug that will complement this aspect.
The main problem with BPS thus seems to be the ‘single induction dose of opioid’ that is used
at the beginning of the procedure in a form of premedication. This overlooks the fact that pain
levels and procedure times differ significantly between ERCP procedures, and may be one of
the factors leading to oversedation due to excessive doses of propofol. By taking this aspect into
consideration, the sedation regimen of the Combination Group of the present study incorpo-
rated the repeated administration of an opioid according to the pain or discomfort of the
patient during ERCP. Although meperidine has been most commonly used by many gastroen-
terologists during endoscopy for a long time,[9] its toxic potential makes it inappropriate for
repeated administrations, and doses as low as 46 mg have been reported to produce central ner-
vous system symptoms.[15] The active metabolite, normeperidine, has a half-life ranging
between 14 to 21 hours, and its accumulation may precipitate anxiety, hyperreflexia, myoclo-
nus, seizures and mood changes.[8] In order to avoid such side effects, fentanyl was used as the
opioid in the Combination Group. Fentanyl has a more rapid onset and clearance, lacks dan-
gerous metabolites or allergenic properties and is therefore commonly recommended as the
safe alternative to meperidine for procedural sedation.[9,16]
Table 5. Satisfaction scores of the endoscopist and patients. Values are median (IQR)
Conventional Group (n = 100) Combination Group (n = 102) P-value•
Endoscopist 90 (80, 100) 90 (80, 100) 0.868
Patient 90 (90, 100) 90 (80, 100) 0.890
• Analyzed with the Mann-Whitney U Test
doi:10.1371/journal.pone.0138422.t005
Table 6. Pain scores and frequency of rescue drug administration. Values are mean ± SD. VAS, visual analogue scale
Conventional Group (n = 100) Combination Group (n = 102) P-value•
Pain score (VAS 0~10)
Post-procedure 6hr 3.2 ± 2.4 2.5 ± 2.5 0.045
Post-procedure 12hr 1.4 ± 2.1 1.6 ± 2.1 0.615
Post-procedure 18hr 1.0 ± 1.6 1.0 ± 1.7 0.898
Post-procedure 24hr 0.9 ± 1.6 0.7 ± 1.4 0.332
Rescue analgesics (n)
Post-procedure 0–12 hrs 0.8 ± 0.9 0.5 ± 0.8 0.023
Post-procedure 12–24 hrs 0.2 ± 0.6 0.2 ± 0.4 0.247
Rescue anti-emetics (n)
Post-procedure 0–12 hrs 0.1 ± 0.5 0.0 ± 0.2 0.07
Post-procedure 12–24 hrs 0.0 ± 0.2 0.0 ± 0.2 0.72
•Analyzed with the independent two sample t-test
doi:10.1371/journal.pone.0138422.t006
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We found in a recent retrospective analysis that providing analgesia by combining repeated
doses of fentanyl with propofol could effectively reduce the risk of respiratory events when
compared with propofol monosedation.[11] This result was attributed to the decreased risk of
oversedation by reducing the overall dosage of propofol. However, it could not be concluded
that repeated doses of fentanyl would not affect recovery profiles. We found in the present
study that the fentanyl combination method did not prolong recovery times or worsen recov-
ery profiles compared to conventional BPS. In other words, repeated administrations of fenta-
nyl did not seem to affect patient recovery when used appropriately for procedural pain
control. In addition, considering the suggested doses of propofol for sedation and maintenance
of general anesthesia (25–75 μg/kg/min and 50–150 μg/kg/min, respectively),[17] the differ-
ence in propofol requirements of roughly 55 μg/kg/min between the two groups seem to have
clinical significance.
The present study is notable in that patients were enrolled regardless of ASA class. While
most previous studies done on sedation protocols enrolled patients of only ASA class 1–3,[18–
21] we also included patients of ASA class 4. However, the incidence of desaturation was very
low in both groups, and all events were corrected with a temporary increase in oxygen supply
without the need to interrupt the procedure.
In terms of post-procedural pain, the Conventional Group showed significantly lower pain
scores compared to the Combination Group at 6 hours after the procedure, and required less
rescue analgesics during the first 12 hours. However, these results should be interpreted care-
fully. The difference in mean VAS scores between the two groups was only 0.7 (3.2 ± 2.4 vs.
2.5 ± 2.5), which may have questionable significance in actual clinical practice. This also applies
to the results of rescue analgesics administration during the first 12 hours, which is statistically
significant, but does not seem to have much clinical significance (0.8 ± 0.9 vs. 0.5 ± 0.8).
Whether the combination method for sedation during ERCP allows lesser post-procedural
pain remains unclear in this study.
This study has several limitations. First, this study was conducted in a single institution and
enrolled only Asian patients that showed a tendency of a relatively low body mass index
(22.9 ± 3.1 kg/m2) compared to the average Caucasian. A study including a patient population
of diverse ethnicity should provide more insight with regard to drug dosage and adverse events.
Secondly, we were not able to detect a difference in respiratory events between the two groups
despite the significant reduction in propofol dosage in the Combination Group. Moreover, the
incidence of respiratory events observed in the present study was under 3% in both groups,
which is much lower than the previously reported 6% in patients that received ERCP proce-
dures under propofol monosedation in a retrospective study.[11] Lastly, patients of the Combi-
nation Group were somewhat older that those of the Conventional Group with a mean age
difference of 5 years. However, to what extent this difference may have affected the drug
requirements and other outcomes are not clear. Overall, these results may imply that the most
important factor in performing safe, yet effective sedation for therapeutic endoscopic proce-
dures is not the sedative regimen, but the meticulous and careful monitoring of the sedation
provider.
In conclusion, combining repeated doses of fentanyl for adequate pain control with contin-
uous propofol infusion does not seem to prolong recovery times compared to a single dose of
meperidine followed by continuous propofol infusion. The resulting decrease in overall propo-
fol dose may have more significance in patients with poor general conditions which are not
uncommon with ERCP. Considering the pharmacologic characteristics of the two opioids and
the trend of higher satisfaction levels of the endoscopists and patients, combination sedation
using repeated administrations of fentanyl with propofol infusion may be a safer and more
effective sedation method compared to conventional BPS with meperidine during ERCP.
Recovery and Satisfaction after Sedation for ERCP
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